Works matching IS 10538569 AND DT 2020 AND VI 29 AND IP 11
Results: 25
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 11, p. 1, doi. 10.1002/pds.4949
- Publication type:
- Article
Methods for external control groups for single arm trials or long‐term uncontrolled extensions to randomized clinical trials.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 11, p. 1382, doi. 10.1002/pds.5141
- By:
- Publication type:
- Article
Development and validation of coding algorithms to identify patients with incident lung cancer in United States healthcare claims data.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 11, p. 1465, doi. 10.1002/pds.5137
- By:
- Publication type:
- Article
CPRD Aurum database: Assessment of data quality and completeness of three important comorbidities.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 11, p. 1456, doi. 10.1002/pds.5135
- By:
- Publication type:
- Article
Navigating stormy waters: 10 years of operation of the European Union Regulatory Network Incident Management Plan for Medicines for Human Use.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 11, p. 1343, doi. 10.1002/pds.5133
- By:
- Publication type:
- Article
Validity of diagnosis and procedure codes for identifying neural tube defects in infants.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 11, p. 1489, doi. 10.1002/pds.5128
- By:
- Publication type:
- Article
Validation of algorithms to estimate gestational age at birth in the Medicaid Analytic eXtract—Quantifying the misclassification of maternal drug exposure during pregnancy.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 11, p. 1414, doi. 10.1002/pds.5126
- By:
- Publication type:
- Article
Randomized, observational, interventional, and real‐world—What's in a name?
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 11, p. 1514, doi. 10.1002/pds.5123
- By:
- Publication type:
- Article
Implementing high‐dimensional propensity score principles to improve confounder adjustment in UK electronic health records.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 11, p. 1373, doi. 10.1002/pds.5121
- By:
- Publication type:
- Article
Can we identify allergic rhinitis from administrative data: A validation study.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 11, p. 1423, doi. 10.1002/pds.5120
- By:
- Publication type:
- Article
High concordance between chart review adjudication and electronic medical record data to identify prevalent and incident diabetes mellitus among persons with and without HIV.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 11, p. 1432, doi. 10.1002/pds.5111
- By:
- Publication type:
- Article
Attention‐deficit/hyperactivity disorder medication and risk of suicide attempt: A meta‐analysis of observational studies.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 11, p. 1364, doi. 10.1002/pds.5110
- By:
- Publication type:
- Article
Outcome misclassification: Impact, usual practice in pharmacoepidemiology database studies and an online aid to correct biased estimates of risk ratio or cumulative incidence.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 11, p. 1450, doi. 10.1002/pds.5109
- By:
- Publication type:
- Article
The recording and prevalence of Inflammatory bowel disease in girls' primary care medical Spanish records.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 11, p. 1440, doi. 10.1002/pds.5107
- By:
- Publication type:
- Article
The controversy around technical standards for similar biotherapeutics: barriers to access and competition?<sup>†</sup>.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 11, p. 1518, doi. 10.1002/pds.5100
- By:
- Publication type:
- Article
Comparison of laboratory threshold criteria in drug‐induced liver injury detection algorithms for use in pharmacovigilance.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 11, p. 1480, doi. 10.1002/pds.5099
- By:
- Publication type:
- Article
Optimizing identification of resistant hypertension: Computable phenotype development and validation.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 11, p. 1393, doi. 10.1002/pds.5095
- By:
- Publication type:
- Article
Opportunities to improve the electronic reporting system for adverse drug reactions in Mexico: A comparative evaluation with the United States of America and the European Union.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 11, p. 1523, doi. 10.1002/pds.5092
- By:
- Publication type:
- Article
Who are we missing? Underrepresentation of data sources used for pharmacoepidemiology research in the United States.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 11, p. 1494, doi. 10.1002/pds.5087
- By:
- Publication type:
- Article
Using real‐world evidence for pharmacovigilance and drug safety‐related decision making by a resource‐limited health authority: 10 years of experience in Taiwan.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 11, p. 1402, doi. 10.1002/pds.5084
- By:
- Publication type:
- Article
Validity of administrative claims‐based algorithms for ventricular arrhythmia and cardiac arrest in the pediatric population.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 11, p. 1499, doi. 10.1002/pds.5001
- By:
- Publication type:
- Article
Challenges facing drug utilization research in the Latin American region.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 11, p. 1353, doi. 10.1002/pds.4989
- By:
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 11, p. 1527, doi. 10.1002/pds.4833
- Publication type:
- Article
Issue Information.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 11, p. 1, doi. 10.1002/pds.4949
- Publication type:
- Article
Improving transparency to build trust in real‐world secondary data studies for hypothesis testing—Why, what, and how: recommendations and a road map from the real‐world evidence transparency initiative.
- Published in:
- Pharmacoepidemiology & Drug Safety, 2020, v. 29, n. 11, p. 1504, doi. 10.1002/pds.5079
- By:
- Publication type:
- Article